Inventor
CHU SEUNG
US25 patents
Patents
25 patentsUS9856327B2Jan 2, 2018
Heterodimeric antibodies to CD3 X CD123
XENCOR INC72 citations98
US11225528B2Jan 18, 2022
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC11 citations94
US10526417B2Jan 7, 2020
Heterodimeric antibodies that bind CD3 and CD38
XENCOR INC27 citations94
US10428155B2Oct 1, 2019
Trispecific antibodies
XENCOR INC39 citations94
US10259887B2Apr 16, 2019
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC25 citations94
US10227410B2Mar 12, 2019
Heterodimeric antibodies that bind CD3 and PSMA
XENCOR INC36 citations94
US10227411B2Mar 12, 2019
Modulation of T cells with bispecific antibodies and FC fusions
XENCOR INC17 citations92
US9850320B2Dec 26, 2017
Heterodimeric antibodies to CD3 X CD20
XENCOR INC13 citations92
US9822186B2Nov 21, 2017
Bispecific antibodies that bind to CD38 and CD3
XENCOR INC17 citations92
US11623957B2Apr 11, 2023
Heterodimeric antibodies that bind CD3 and PSMA
XENCOR INC9 citations86
US11472890B2Oct 18, 2022
Heterodimeric antibodies that bind ENPP3 and CD3
XENCOR INC9 citations84
US10982006B2Apr 20, 2021
Heterodimeric antibodies that bind fibroblast activation protein
XENCOR INC8 citations84
US11945880B2Apr 2, 2024
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US11859011B2Jan 2, 2024
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US10913803B2Feb 9, 2021
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US10889653B2Jan 12, 2021
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC2 citations73
US12359002B2Jul 15, 2025
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC0 citations62
US12180302B2Dec 31, 2024
Heterodimeric antibodies that bind fibroblast activation protein
XENCOR INC0 citations62
US12129309B2Oct 29, 2024
Heterodimeric antibodies that bind CD3 and CD38
XENCOR INC0 citations62
US11840579B2Dec 12, 2023
Bispecific antibodies that bind to CD38 and CD3
XENCOR INC0 citations62
US11673972B2Jun 13, 2023
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC0 citations62
US11111315B2Sep 7, 2021
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC0 citations62
US11091548B2Aug 17, 2021
Modulation of T cells with bispecific antibodies and Fc fusions
XENCOR INC0 citations60
US10544187B2Jan 28, 2020
Targeting regulatory T cells with heterodimeric proteins
XENCOR INC1 citations59
US10519242B2Dec 31, 2019
Targeting regulatory T cells with heterodimeric proteins
XENCOR INC0 citations48